Activating CaSR in macrophages, which are prominent in adipose tissues, induces inflammation in preadipocytes via the NLRP3 inflammasome pathway suggesting that interfering with the expression of CaSR in obesity could work as a therapeutic mechanism. The gene discussed is CASR; the disease is obesity due to melanocortin 4 receptor deficiency.